News
Oct 1, 2021 For Immediate Release – Fibrocor Therapeutics Inc, a precision medicine company developing first in class drugs for IPF and other fibrotic diseases, is participating at the upcoming Piper Sandler Lung Day conference […]
Fibrocor is pleased to be presenting at TSX Life Sciences Investor Day
Mechelen, Belgium and Toronto, Canada; 15 January 2020, 7.30 CET – Galapagos NV (Euronext & NASDAQ: GLPG) and Fibrocor Therapeutics Inc. (Fibrocor) today announced an expanded collaboration focused on novel targets in fibrosis, with Galapagos […]
Mechelen, Belgium; December 2018, 22.01 CET – Fibrocor Therapeutics L.P. (Fibrocor), a privately held Canadian company, and Galapagos NV (Euronext & NASDAQ: GLPG) announced a global partnership focused on a novel target for idiopathic pulmonary […]
